Improving the Patient Experience With Longer Wear Infusion Sets Symposium Report

Kevin T Nguyen, Nicole Y Xu, Bruce A Buckingham, Sarnath Chattaraj, Ohad Cohen, Lutz Heinemann, John Pickup, Jannet Svensson, Robert A Vigersky, Jenise C Wong, Ralph Ziegler

4 Citations (Scopus)


Continuous subcutaneous insulin infusion (CSII) therapy is becoming increasingly popular. CSII provides convenient insulin delivery, precise dosing, easy adjustments for physical activity, stress, or illness, and integration with continuous glucose monitors in hybrid or other closed-loop systems. However, even as insulin pump hardware and software have advanced, technology for insulin infusion sets (IISs) has stayed relatively stagnant over time and is often referred to as the "Achilles heel" of CSII. To discuss barriers to insulin pump therapy and present information about advancements in, and results from clinical trials of extended wear IISs, Diabetes Technology Society virtually hosted the "Improving the Patient Experience with Longer Wear Infusion Sets Symposium" on December 1, 2021. The symposium featured experts in the field of IISs, including representatives from Steno Diabetes Center Copenhagen, University of California San Francisco, Stanford University, Medtronic Diabetes, and Science Consulting in Diabetes. The webinar's seven speakers covered (1) advancements in insulin pump therapy, (2) efficacy of longer wear infusion sets, and (3) innovations to reduce plastics and insulin waste.

Original languageEnglish
JournalJournal of diabetes science and technology
Issue number3
Pages (from-to)775-782
Number of pages8
Publication statusPublished - May 2022


  • Diabetes Mellitus, Type 1/drug therapy
  • Humans
  • Hypoglycemic Agents
  • Insulin
  • Insulin Infusion Systems
  • Patient Outcome Assessment


Dive into the research topics of 'Improving the Patient Experience With Longer Wear Infusion Sets Symposium Report'. Together they form a unique fingerprint.

Cite this